1. The renaissance of centrally acting antihypertensive drugs;Van Zwieten;J Hypertens,1999
2. Monoxidine decreases both cardiac and peripheral sympathetic activity in healthy volunteers;Wenzel;Kidney Blood Press Res,1996
3. Moxonidine a centrally acting antihypertensive agent is a selective ligand for I1-imidazoline sites;Ernsberger;J Pharmacol Exp Ther,1993
4. Effects of moxonidine on stress-induced peak blood pressure and renal function: a randomised, double-blind, placebo-controlled crossover study;Fauvel;J Cardiovasc Pharmacol,1998
5. Demonstration of hypertrophy regression with magnetic resonance tomography under the new adrenergic inhibitor monoxidine;Eichstaed;Cardiovasc Drugs Ther,1989